Comparing the Effects of Oral Contraceptives Containing Levonorgestrel With Products Containing Antiandrogenic Progestins on Clinical, Hormonal, and Metabolic Parameters and Quality of Life in Women With Polycystic Ovary Syndrome: Crossover Randomized Controlled Trial Protocol

BACKGROUND: Oral contraceptives (OCs) have been used as a first-line option for medical treatment in women with polycystic ovary syndrome (PCOS). Despite theoretical superiority of products containing antiandrogenic progestins compared to OCs containing levonorgestrel (LNG), the clinical advantage o...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:JMIR Res Protoc
Auteurs principaux: Amiri, Mina, Nahidi, Fatemeh, Khalili, Davood, Bidhendi-Yarandi, Razieh, Ramezani Tehrani, Fahimeh
Format: Artigo
Langue:Inglês
Publié: JMIR Publications 2017
Sujets:
Protocol
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5640820/
https://ncbi.nlm.nih.gov/pubmed/28963092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2196/resprot.8631
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires